Innovating Works

CRL

Desconocido
SKIP-NMD: A phase I IIa clinical trial in Duchenne muscular dystrophy using systemically delivered morpholino... CHARLES RIVER LABORATORIES PRECLINICAL SERVICES EDINBURGH LTD participó en un FP7: Duchenne muscular dystrophy (DMD) is a progressive, lethal muscle degenerative condition arising from the absence of dystrophin in skeletal...
Financiado
* Datos extraídos de la documentos o webs disponibles en diferentes organismos públicos.